Metal Ion Responsive Fluorescent Probes
FULL PAPER
122.43, 95.69, 15.67, 15.57 ppm; 19F NMR (CDCl3, 300 MHz):
d
=
51.22, 46.27 ppm; HRMS (+ESI): m/z: calcd for C36H40N5O5: 622.3029;
found: 622.3065.
ꢀ146.6 ppm (m, 2F); EI-MS: m/z (%): 348 (100) [M+].
General CuAAC procedure: The reaction followed the literature.[145] To
the stirred suspension of Cu/C (0.1 equiv) in THF (3 mL) was added trie-
thylamine (1.0 equiv) followed by the azide derivative (1.0 equiv) and the
acetylene derivative (1.0 equiv). The reaction mixture was stirred at 608C
for 16 h after which an additional portion of the Cu/C (0.1 equiv) was
added. It was heated for two days and cooled to room temperature
before the Cu/C was filtered off through celite. Concentration of the sol-
ution gave the crude product which was purified by column chromatogra-
phy.
10-Methyl-9-{4-[4-(1,4,7,10,13-pentaoxa-16-azacyclooctadecan-16-yl)phen-
yl]-1H-1,2,3-triazol-1-yl}-methylanthracene (5): Compounds 16 and 24
were reacted according to the general CuAAC procedure. The crude
product was purified by column chromatography (CHCl3/MeOH 97:3 v/
v) with subsequent recrystallization from CH2Cl2/nhexane/ethyl acetate
1:1:0.25 v/v/v), to give 5 in form of brownish crystals (64 mg, 48%). M.p.
148.7–151.38C; 1H NMR (CDCl3, 500 MHz): d = 8.41 (dd, 2H, J=7.65,
0.60 Hz, H2), 8.41–8.31 (m, 2H, H5), 7.61–7.56 (m, 4H, H3, H4), 7.44 (d,
2H, J=8.9 Hz, H8), 7.11 (s, 1H, H7), 6.57 (d, 2H, J=8.9 HZ, H9), 6.55 (s,
2H, H6), 3.66–3.56 (m, 24H, H10–15), 3.19 ppm (s, 3H, H1); 13C NMR
(CDCl3, 125 MHz): d = 148.29, 147.73, 133.90, 130.73, 130.14, 127.22,
126.84, 126.15, 125.89, 125.44, 123.88, 122.50, 118.39, 117.71, 111.67, 70.97,
70.92, 70.87, 70.82, 68.74, 51.35, 46.79, 14.78 ppm; HRMS (+ESI): m/z
calcd for C36H43N4O5: 611.3233; found: 611.3279.
2-Butyl-6-{1-[4-(1,4,7,10,13-pentaoxa-16-azacyclooctadecan-16-yl)phenyl]-
1H-1,2,3-triazol-4-yl}-1H-benzo[de]isoquinoline-1,3(2H)-dione (1): Com-
pounds 17 and 20 (Supporting Information) were reacted according to
the general CuAAC procedure. The crude product was purified by
column chromatography (silica gel, CHCl3/MeOH 98:2 v/v) to yield 1 as
a yellow solid (0.086 g, 49%). M.p. 136.1–139.08C; 1H NMR (CDCl3,
600 MHz): d = 9.1 (dd, 1H, J=8.55, 1.05 Hz, H9), 8.63 (dd, 1H, J=7.02,
1.02 Hz, H7), 8.61 (d, 1H, J=8.55 Hz, H5), 8.26 (s, 1H, H10), 7.99 (d, 1H,
J=7.56 Hz, H6), 7.79 (dd, 1H, J=8.52, 7.26 Hz, H8), 7.61 (d, 2H, J=
9.12 Hz, H11), 6.81 (d, 2H, J=9.12 Hz, H12), 4.18 (t, 2H, J=7.62 Hz, H4),
3.74–3.64 (m, 24H, H13–18), 1.76–1.69 (m, 2H, H3), 1.45 (sx, 2H, J=
7.62 Hz, H2), 0.98 ppm (t, 3H, J=7.38 Hz, H1); 13C NMR (CDCl3,
150 MHz): d = 164.34, 164.06, 148.68, 146.15, 145.66, 134.32, 132.92,
131.52, 130.81, 129.40, 128.95, 127.48, 127.35, 125.96, 122.94, 122.56,
121.52, 111.99, 70.98–70.82,68.8, 68.60, 51.59, 40.41, 30.32, 20.52,
13.99 ppm; HRMS (+ESI): m/z: calcd for C36H44N5O7: 658.3242; found:
658.3220.
4,4-Difluoro-8-(4-{1-[4-(1,4,7,10,13-pentaoxa-16-azacyclooctadecan-16-yl)-
phenyl]-1H-1,2,3-triazol-4-yl}phenyl)-1,3,7,9-tetramethyl-4-bora-3a,4a-
diaza-s-indacene (6): Compounds 17 and 25 were reacted according to
the general CuAAC procedure. Crude 6 was purified by column chroma-
tography (silica gel, CHCl3/MeOH/hexane 80:7:13 v/v/v) to give 6 in the
form of reddish crystals (0.040 g, 28%). M.p. 197.2199.48C; 1H NMR
(CDCl3, 600 MHz): d = 8.14 (s, 1H, H6), 8.04 (d, 2H, J=8.3 Hz, H5), 7.56
(d, 2H, J=8.9 Hz, H7), 7.38 (d, 2H, J=8.3 Hz, H4), 6.79 (d, 2H, J=
8.9 Hz, H8), 5.99 (s, 2H, H3), 3.75 (t, 4H, J=5.5 Hz, H9), 7.70–3.76 (m,
20H, H10–14), 2.57 (s, 6H, H2), 1.46 ppm (s, 6H, H1); 13C NMR (CDCl3,
150 MHz): d = 155.72, 147.24, 143.27, 141.41, 134.90, 131.54, 128.77,
126.52, 122.36, 121.42, 118.28, 111.99, 71.02, 70.97, 70.93, 68.65, 51.63,
29.85, 14.79 ppm; 19F NMR (CDCl3, 300 MHz): d = ꢀ146.7 ppm (m, 2F);
HRMS (+ESI): m/z calcd for C39H48BF2N6O5: 729.3747; found: 729.3746.
2-Ethyl-6-{4-[4-(1,4,7,10,13-pentaoxa-16-azacyclooctadecan-16-yl)phenyl]-
1H-1,2,3-triazol-1-yl}-1H-benzo[de]isoquinoline-1,3(2H)-dione (2): Com-
pounds 16 and 21 (Supporting Information) were reacted according to
the general CuAAC procedure. The crude product was purified by
column chromatography (silica gel, CHCl3/MeOH 95:5 v/v) to yield 2 as
an orange solid (0.024 g, 19%). M.p. 213.6–216.48C; 1H NMR (CDCl3,
600 MHz): d = 8.71 (t, 2H, J=7.47 Hz, H3, H5), 8.36 (d, 1H, J=8.1 Hz,
H7), 8.09 (s, 1H, H8), 7.89 (d, 1H, J=7.47 Hz, H4), 7.83 (tr, 1H, J=
5.26 Hz, H6), 7.79 (d, 2H, J=8.7 Hz, H9), 6.79 (d, 2H, J=8.82 Hz, H10),
4.28 (q, 2H, J=7.12 Hz, H2), 3.74–3.68 (m, 24H, H11–16), 1.36 ppm (t, 3H,
J=7.12 Hz, H1); 13C NMR (CDCl3, 150 MHz): d = 163.68, 163.16, 149.13,
148.48, 138.59, 132.29, 130.82, 129.87, 129.29, 128.63, 127.31, 126.71,
123.93, 123.46, 123.19, 120.20, 117.23, 112.01, 71.04–70.93, 68.82, 51.50,
35.93, 13.47 ppm; HRMS (+ESI): m/z: calcd for C34H40N5O7: 630.2928;
found: 630.2883.
9-{1-[4-(1,4,7,10,13-Pentaoxa-16-azacyclooctadecan-16-yl)phenyl]-1H-
1,2,3-triazol-4-yl}-anthracene (7): Compounds 17 and 18 were reacted ac-
cording to the general CuAAC procedure. The crude product was puri-
fied by column chromatography (65ꢄ2 cm, silica gel, CHCl3/MeOH 95:5
v/v) to yield 7 as a light brown oil (0.021 g, 23%). 1H NMR (CDCl3,
300 MHz): d=8.56 (s, 1H, H1), 8.11 (s, 1H, H6), 8.10–8.00 (m, 2H, H2),
7.99–7.93 (m, 2H, H5), 7.55–7.40 (m, 4H, H3, H4), 6.87 (d, 2H, J=
9.12 Hz, H7), 6.67 (d, 2H, J=9.12 Hz, H8), 3.73–3.59 ppm (m, 24H, H9–
14);13C NMR (CDCl3, 75 MHz):d= 145.62, 148.02, 131.34, 131.02, 128.64,
126.89, 126.07, 124.54, 125.48, 125.21, 122.07, 119.95, 111.24, 70.85, 68.37,
51.16 ppm; MS (+ESI): m/z calcd for C34H39N4O5: 583.29; found: 583.34.
2-Ethyl-6-(4-octyl-1H-1,2,3-triazol-1-yl)-1H-benzo[de]isoquinoline-
1,3(2H)-dione (9): 1-Decyne (0.021 g, 0.015) and 21 (0.04 g, 0.15 mmol)
were reacted according to the general CuAAC procedure. The crude
product was purified by column chromatography (silica gel, CHCl3/
MeOH 250:1 v/v) to give 9 as an orange semi-solid (38 mg, 63%).
1H NMR (CDCl3, 600 MHz): d = 8.68 (d, 2H, J=7.44 Hz, H9, H5), 8.27
(d, 1H, J=8.58 Hz, H8), 7.83–7.80 (m, 2H, H8,H6), 7.78 (s, 1H, H10), 4.26
(q, 2H, J=7.08 Hz, H2), 2.8 8(t, 2H, J=7.77 Hz, H11), 1.80 (qu, 2H, H12),
1.30 (m, 2H, H13), 1.39–1.24 (m, 11H, H1, H14–18), 0.88 ppm (t, 3H, J=
7.0 Hz, H18); 13C NMR (CDCl3, 150 MHz): d = 163.63, 163.12, 149.41,
138.62, 132.24, 130.77, 129.76, 129.22, 128.58, 126.66, 123.87, 123.16,
123.14, 35.90, 31.99, 29.50, 29.47, 29.37, 25.78, 22.80, 14.24, 13.44 ppm;
MS (EI): m/z (%): 404 (100) [M+].
9-4-[4-(1,4,7,10,13-Pentaoxa-16-azacyclooctadecan-16-yl)phenyl]-1H-
1,2,3-triazol-1-yl}-methylanthracene (3): Compounds 16 and 22 were re-
acted according to the general CuAAC procedure. The crude product
was purified by column chromatography (silica gel, CHCl3/MeOH 97:3 v/
v) to give
3 as a
yellow solid (0.029 g, 22%). 1H NMR (CDCl3,
600 MHz): d = 8.59 (s, 1H, H1), 8.36 (d, 2H, J=8.70 Hz, H5), 8.09 (d,
2H, J=8.2 Hz, H2), 7.74–7.44 (m, 6H, J=8.2 Hz, H4,H3, H8, H2, H3), 7.15
(s, 1H, H7), 6.59 (d, 2H, J=8.65 Hz, H9), 6.55(s, 2H, H6) 3.72–3.49 ppm
(m, 24H, H10–15); 13C NMR (CDCl3, 150 MHz):
d = 148.40, 147.78,
131.66, 131.06, 129.91, 129.58, 127.77, 126.87, 125.57, 124.18, 123.27,
118.37, 117.66, 111.70, 70.98, 70.94, 70.89, 70.84, 68.76, 51.39 ppm; HRMS
(+ESI): m/z calcd for C35H41N4O5: 597.3070; found: 597.3120.
1-1-[4-(1,4,7,10,13-Pentaoxa-16-azacyclooctadecan-16-yl)phenyl]-1H-
1,2,3-triazol-4-yl}-octan (10): Compound 17 (0.05 g, 0.13 mmol) and 1-
decyne (0.018 g, 0.13 mmol) were dissolved in THF/water (3:1 v/v, 4 mL)
and CuSO4 (1.7 mg, 0.007 mmol, 5 mol%) and sodium ascorbate (2.6 mg,
0.013 mmol, 10 mol%) were added.[66] The reaction mixture was stirred
at 608C for 16 h. Aqueous NH4Cl (10%, 4 mL) was added and the THF
was removed under reduced pressure. The aqueous layer was extracted
with dichloromethane (3ꢄ7 mL), the organic layer was dried with
MgSO4 and concentrated. The crude product was purified by column
chromatography (silica gel, ethyl acetate/MeOH 7:3) to give 11 as a
greenish oil (0.072 g, >99%). 1H NMR (CDCl3, 300 MHz): d = 7.56 (s,
1H, H9), 7.58 (d, 2H, J=9.04 Hz, H10), 6.76 (d, 2H, J=7.35 Hz, H11),
3.74–3.66 (m, 24H, H12–17), 2.76 (tr, 2H, J=7.53 Hz, H8), 1.71 (qu, 2H,
J=7.72 Hz, H7), 1.41–1.22 (m, 10H, H2–6), 0.87 ppm (tr, 3H, J=6.97 Hz,
10-Cyano-9-{4-[4-(1,4,7,10,13-pentaoxa-16-azacyclooctadecan-16-yl)phen-
yl]-1H-1,2,3-triazol-1-yl}-methylanthracene (4): Compounds 16 and 23
were reacted according to the general CuAAC procedure. Crude 4 was
purified by column chromatography (silica gel, CHCl3/MeOH 97:3 v/v)
with subsequent recrystallization from CH2Cl2/petrol ether (50–708C) 1:1
v/v, to give yellow crystals (0.028 g, 20%). M.p. 199.5–203.98C; 1H NMR
(CDCl3, 600 MHz): d = 8.53 (d, 2H, J=8.64 Hz, H1), 8.49 (d, 2H, J=
8.76 Hz, H4), 7.77 (m, 2H, H2), 7.72 (m, 2H, H3), 7.45 (d, 2H, J=9.0 Hz,
H7), 7.18 (s, 1H, H6), 6.59 (d, 2H, J=8.8 Hz, H8), 6.57 (s, 2H, H5), 3.65–
3.56 ppm (m, 24H, H9–15); 13C NMR (CDCl3, 150 MHz): d = 148.68,
147.83, 133.00, 130.78, 130.05, 128.94, 128.52, 126.77, 126.59, 124.02,
117.74, 117.34, 116.81, 111.57, 108.84, 70.85, 70.80, 70.75, 70.70, 68.59,
Chem. Eur. J. 2013, 00, 0 – 0
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
13
&
ÞÞ
These are not the final page numbers!